Anti-Human CD47/MER6 Antibody (5F9-G4)
The Anti-Human CD47/MER6 Antibody (5F9-G4) is a highly specific and potent antibody designed for use in biotech research. This innovative antibody targets the CD47 protein, also known as MER6, which is a key regulator of immune response and cell survival.
The biological function of CD47 is to act as a “don’t eat me” signal, preventing immune cells from attacking healthy cells. However, in certain diseases such as cancer, this function can be exploited by tumor cells to evade the immune system. The Anti-Human CD47/MER6 Antibody (5F9-G4) blocks this signal, allowing the immune system to recognize and eliminate cancer cells.
This antibody has a wide range of applications, making it a valuable tool for researchers in the field of biotechnology. It can be used in studies related to cancer, autoimmune diseases, and other disorders involving immune dysfunction. The Anti-Human CD47/MER6 Antibody (5F9-G4) has also shown promising results in pre-clinical trials as a potential treatment for various types of cancer.
In experimental use cases, the Anti-Human CD47/MER6 Antibody (5F9-G4) has been shown to enhance the activity of other cancer therapies, such as chemotherapy and immunotherapy. It has also been found to have a synergistic effect when combined with other immune checkpoint inhibitors. This makes it a valuable addition to any biotech research project focused on developing new treatments for cancer.
With its high specificity and potency, the Anti-Human CD47/MER6 Antibody (5F9-G4) is a reliable and effective tool for biotech researchers. Its ability to target and block the CD47 protein makes it a valuable asset in the fight against cancer and other diseases. Order now and take your research to the next level with this cutting-edge antibody.
Keywords: Anti-Human CD47/MER6 Antibody (5F9-G4), biotech research, CD47 protein, immune response, cell survival, cancer, autoimmune diseases, immune dysfunction, pre-clinical trials, cancer therapies, chemotherapy, immunotherapy, immune checkpoint inhibitors, high specificity, potency, reliable, effective, target, block, fight against cancer, cutting-edge antibody.
There are no reviews yet.